OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis

Summary

This is an early phase safety evaluation of the use of oral extended release (OER) glibenclamide, which is otherwise known as glyburide, for use as a treatment for neurologic pain in people with multiple sclerosis. Patients will receive medication to assess safety and tolerability.

Timeline

Start

2026-09-01

Primary completion

2028-09-01

Completion

2029-09-01

Drugs

Indications